Unknown

Dataset Information

0

Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.


ABSTRACT: PURPOSE:The perturbation of metabolic pathways in high-grade bladder cancer has not been investigated. We aimed to identify a metabolic signature in high-grade bladder cancer by integrating unbiased metabolomics, lipidomics, and transcriptomics to predict patient survival and to discover novel therapeutic targets. EXPERIMENTAL DESIGN:We performed high-resolution liquid chromatography mass spectrometry (LC-MS) and bioinformatic analysis to determine the global metabolome and lipidome in high-grade bladder cancer. We further investigated the effects of impaired metabolic pathways using in vitro and in vivo models. RESULTS:We identified 519 differential metabolites and 19 lipids that were differentially expressed between low-grade and high-grade bladder cancer using the NIST MS metabolomics compendium and lipidblast MS/MS libraries, respectively. Pathway analysis revealed a unique set of biochemical pathways that are highly deregulated in high-grade bladder cancer. Integromics analysis identified a molecular gene signature associated with poor patient survival in bladder cancer. Low expression of CPT1B in high-grade tumors was associated with low FAO and low acyl carnitine levels in high-grade bladder cancer, which were confirmed using tissue microarrays. Ectopic expression of the CPT1B in high-grade bladder cancer cells led to reduced EMT in in vitro, and reduced cell proliferation, EMT, and metastasis in vivo. CONCLUSIONS:Our study demonstrates a novel approach for the integration of metabolomics, lipidomics, and transcriptomics data, and identifies a common gene signature associated with poor survival in patients with bladder cancer. Our data also suggest that impairment of FAO due to downregulation of CPT1B plays an important role in the progression toward high-grade bladder cancer and provide potential targets for therapeutic intervention.

SUBMITTER: Vantaku V 

PROVIDER: S-EPMC6571061 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Multi-omics Integration Analysis Robustly Predicts High-Grade Patient Survival and Identifies CPT1B Effect on Fatty Acid Metabolism in Bladder Cancer.

Vantaku Venkatrao V   Dong Jianrong J   Ambati Chandrashekar R CR   Perera Dimuthu D   Donepudi Sri Ramya SR   Amara Chandra Sekhar CS   Putluri Vasanta V   Ravi Shiva Shankar SS   Robertson Matthew J MJ   Piyarathna Danthasinghe Waduge Badrajee DWB   Villanueva Mariana M   von Rundstedt Friedrich-Carl FC   Karanam Balasubramanyam B   Ballester Leomar Y LY   Terris Martha K MK   Bollag Roni J RJ   Lerner Seth P SP   Apolo Andrea B AB   Villanueva Hugo H   Lee MinJae M   Sikora Andrew G AG   Lotan Yair Y   Sreekumar Arun A   Coarfa Cristian C   Putluri Nagireddy N  

Clinical cancer research : an official journal of the American Association for Cancer Research 20190307 12


<h4>Purpose</h4>The perturbation of metabolic pathways in high-grade bladder cancer has not been investigated. We aimed to identify a metabolic signature in high-grade bladder cancer by integrating unbiased metabolomics, lipidomics, and transcriptomics to predict patient survival and to discover novel therapeutic targets.<h4>Experimental design</h4>We performed high-resolution liquid chromatography mass spectrometry (LC-MS) and bioinformatic analysis to determine the global metabolome and lipido  ...[more]

Similar Datasets

| S-EPMC9259796 | biostudies-literature
| S-EPMC6050171 | biostudies-literature
| S-EPMC9906958 | biostudies-literature
| S-EPMC9061712 | biostudies-literature
| S-EPMC7848834 | biostudies-literature
| S-EPMC9251488 | biostudies-literature
| S-EPMC8717782 | biostudies-literature
| S-EPMC8658754 | biostudies-literature
| S-EPMC5059772 | biostudies-literature
| S-EPMC9126043 | biostudies-literature